Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Open accessThe DOI matches its Crossref record; 234 of the 236 references it cites were found in a registry or an index; 50 of the 187 sources its claims cite were checked for support.
Abstract
Organisms are continually exposed to exogenous and endogenous sources of reactive oxygen species (ROS) and other oxidants that have both beneficial and deleterious effects on the cell. ROS have important roles in a wide range of physiological processes; however, high ROS levels are associated with oxidative stress and disease progression. Oxidative stress has been implicated in nearly all major human diseases, from neurogenerative diseases and neuropsychiatric disorders to cardiovascular disease, diabetes, and cancer. Antioxidant defence systems have evolved as a means of protection against oxidative stress, with the transcription factor Nrf2 as the key regulator. Nrf2 is responsible for regulating an extensive panel of antioxidant enzymes involved in the detoxification and elimination of oxidative stress and has been extensively studied in the disease contexts. This review aims to provide the reader with a general overview of oxidative stress and Nrf2, including basic mechanisms of Nrf2 activation and regulation, and implications in various major human diseases.
Overview
CoChat Summary
TL;DR
This narrative review summarizes oxidative stress and the Keap1-Nrf2 antioxidant pathway, covering Nrf2 activation, regulation, and interacting proteins. It highlights Nrf2 as the master regulator of antioxidant and phase II enzymes, with protective roles in many diseases but also a harmful “dark side” in cancer.
Key findings
- Nrf2 is the key transcriptional regulator of ARE-driven antioxidant and phase II enzyme genes; under basal conditions Nrf2 has a short half-life of only 10–30 min, and Keap1 mediates its Cul3-dependent ubiquitination and proteasomal degradation.
- Keap1 senses oxidative stress through reactive cysteines: human Keap1 contains 27 cysteine residues, about 4% of its amino acid content versus a 2% average for the human proteome; Cys273 and Cys288 are required for sensing oxidative stress under basal and stress conditions, while Cys151 may be required only during oxidative stress.
- The Keap1-Nrf2 two-site recognition model depends on the high-affinity ETGE motif and low-affinity DLG motif; the ETGE motif has a binding affinity two orders of magnitude higher than the DLG motif, making DLG an “on/off switch” for Nrf2 ubiquitination.
- Nrf2 is implicated in major human diseases: reduced nuclear Nrf2 is observed in Alzheimer’s disease brain regions; Nrf2 pathway alterations occur in 34% of squamous cell lung cancer specimens; and Nrf2 hyperactivation can promote chemoresistance to drugs such as cisplatin, 5-fluorouracil, docetaxel, and bortezomib.
Methods
- Design: narrative review providing a general overview of oxidative stress, Nrf2 mechanisms, and implications in human disease.
- Data or sample: no primary experimental data or human/animal sample; the paper synthesizes published literature and cites prior studies, reviews, and model-organism findings.
- Main analysis: descriptive synthesis of ROS/RNS biology, antioxidant enzymes, ARE regulation, canonical and non-canonical Keap1-Nrf2 regulation, Nrf2-interacting proteins, and disease associations including neurodegenerative disease, neuropsychiatric disorders, cardiovascular disease, diabetes, cancer, inflammation, and aging.
Limitations
- The paper does not state formal limitations; it describes the review as a “general overview” and notes that several topics are “briefly discussed” or “beyond the scope of this review.”
- Evident from the text: as a narrative review, it lacks a systematic search strategy, predefined inclusion criteria, or quantitative synthesis, and it presents no primary data.
- Evident from the text: disease sections are broad and selective rather than exhaustive, and the authors repeatedly refer readers to other reviews for more detailed discussion.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
23 Valid · 5 Not valid · 72 Not checked · 17 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“WTX is also involved in oxidative stress regulation through its competitive binding to the Keap1, which inhibits Nrf2 ubiquitination [84].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.7. Keap1-Interacting Proteins
What the sources say
- Disputedcites [84] Copple I.M. Lister A. Obeng A.D. Kitteringham N.R. Jenkins R.E. Layfield R. Foster B.J. Goldring C.E. Park B.K. Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway J. Biol. Chem. 2010 285 16782 16788 10.1074/jbc.M109.096545 20378532 PMC2878012 sourceExperimental — accuracy not yet measured
The Discussion attributes competitive binding to Keap1 and reduced Nrf2 ubiquitination to SQSTM1 (p62), not WTX. The paper’s stated mechanism therefore identifies a different protein from the one in the citing sentence; no page number is available in our copy. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Chronic oxidative stress and the resultant oxidative damage have been implicated in many human diseases including cardiovascular disease, neurodegenerative diseases, diabetes, cancer, and the aging process [18,19,20,21,22].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 1. Oxidative Stress > 1.2. Oxidative Stress
What the sources say
- Partly supportedcites [18] Reuter S. Gupta S.C. Chaturvedi M.M. Aggarwal B.B. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic. Biol. Med. 2010 49 1603 1616 10.1016/j.freeradbiomed.2010.09.006 20840865 PMC2990475 sourceExperimental — accuracy not yet measured
The Introduction links sustained oxidative stress and cellular damage to cancer, and describes increased oxidative stress and accumulated molecular damage in aging. The passages from the body of our copy do not substantiate the additional claims about cardiovascular disease, neurodegenerative diseases, or diabetes; those conditions appear in the retrieved reference titles. (LLM, conf=0.84)
- Partly supportedcites [19] Alfadda A.A. Sallam R.M. Reactive Oxygen Species in Health and Disease J. Biomed. Biotechnol. 2012 2012 936486 10.1155/2012/936486 22927725 PMC3424049 sourceExperimental — accuracy not yet measured
The Introduction (section 1; page unavailable) links ROS to cancer, diabetes, cardiovascular disease, and aging, and section 5.3 links oxidative stress to diabetic complications. The passages found do not establish the claimed link to neurodegenerative diseases or characterize the whole disease list specifically as consequences of chronic oxidative stress and resultant damage. (LLM, conf=0.84)
- Partly supportedcites [20] Asmat U. Abad K. Ismail K. Diabetes mellitus and oxidative stress—A concise review Saudi Pharm. J. 2016 24 547 553 10.1016/j.jsps.2015.03.013 27752226 PMC5059829 sourceExperimental — accuracy not yet measured
The 'Oxidative stress and antioxidants' section links oxidative damage to a wide variety of diseases, notably cancer and heart disease. 'Oxidative stress and diabetic complications' also links oxidative stress to diabetes and coronary artery disease. Our copy does not establish the claimed link to neurodegenerative diseases or aging; it mentions aging as a possible factor contributing to oxidative stress, not as a resulting condition. No page numbers are available in our copy. (LLM, conf=0.86)
- Supportedcites [21] Liguori I. Russo G. Curcio F. Bulli G. Aran L. Della-Morte D. Gargiulo G. Testa G. Cacciatore F. Bonaduce D. Oxidative stress, aging, and diseases Clin. Interv. Aging 2018 13 757 772 10.2147/CIA.S158513 29731617 PMC5927356 source
The sections on cardiovascular disease, diabetes, cognitive impairment and dementia, and cancer each link oxidative stress or oxidative damage to the named conditions. The section on the theory of aging describes accumulated oxidative damage as a proposed explanation for age-related functional loss. Page numbers are not available in our copy. (LLM, conf=0.92)
- Not checked yetcites [22] Barnham K.J. Masters C.L. Bush A.I. Neurodegenerative diseases and oxidative stress Nat. Rev. Drug Discov. 2004 3 205 214 10.1038/nrd1330 15031734 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Nrf2 regulates the expression of a multitude of antioxidant and phase II enzyme genes and is negatively regulated by Kelch-like ECH-associated protein (Keap1) [49], a substrate adaptor protein that binds to Nrf2 in the cytosol to facilitate its polyubiquitination by the Cullin 3 (Cul3) E3 ubiquitin ligase for proteasomal degradation [50,51,52].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.1. Keap1-Nrf2 Signalling
What the sources say
- Supportedcites [49] Itoh K. Wakabayashi N. Katoh Y. Ishii T. Igarashi K. Engel J.D. Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain Genes Dev. 1999 13 76 86 10.1101/gad.13.1.76 9887101 PMC316370 source
The Abstract states that Keap1 suppresses Nrf2 transcriptional activity by binding its amino-terminal regulatory domain. The Discussion also describes Nrf2 as sequestered in the cytoplasm through its association with Keap1. This source is cited for negative regulation by Keap1; the later Cul3, polyubiquitination, and degradation mechanism is attached to citations [50–52], not this one. (LLM, conf=0.94)
- Supportedcites [50] Nguyen T. Sherratt P.J. Huang H.C. Yang C.S. Pickett C.B. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome J. Biol. Chem. 2003 278 4536 4541 10.1074/jbc.M207293200 12446695 source
Citation [49] is attached to the claim that Keap1 negatively regulates Nrf2. The paper describes Keap1 retaining Nrf2 in the cytoplasm and says that their dissociation allows Nrf2 to enter the nucleus (introductory passage and Discussion). The subsequent Cul3 polyubiquitination mechanism is attached to citations [50–52], not this source. (LLM, conf=0.92)
- Supportedcites [51] Kobayashi A. Kang M.I. Okawa H. Ohtsuji M. Zenke Y. Chiba T. Igarashi K. Yamamoto M. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2 Mol. Cell. Biol. 2004 24 7130 7139 10.1128/MCB.24.16.7130-7139.2004 15282312 PMC479737 source
The Abstract states that Keap1 retains Nrf2 in the cytoplasm, binds it directly, and acts as an adaptor for Cul3-based E3 ligase in its proteasomal degradation. The Results report ubiquitin-chain conjugation and show that Nrf2 ubiquitination depends on its interaction with Keap1. (LLM, conf=0.93)
- Not checked yetcites [52] McMahon M. Itoh K. Yamamoto M. Hayes J.D. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression J. Biol. Chem. 2003 278 21592 21600 10.1074/jbc.M300931200 12682069 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Oxidative damage has been implicated in all major neurodegenerative diseases including Alzheimer’s disease (AD) [108,109], Parkinson’s disease (PD) [110,111], Huntington’s disease (HD) [112,113], amyotrophic lateral sclerosis (ALS) [114], and multiple sclerosis (MS) [115].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 3. Nrf2 in Human Disease > 3.1. Neurodegenerative Disease
What the sources say
- Supportedcites [108] Smith M.A. Rottkamp C.A. Nunomura A. Raina A.K. Perry G. Oxidative stress in Alzheimer’s disease Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 2000 1502 139 144 10.1016/S0925-4439(00)00040-5 10899439 source
This source is cited for the Alzheimer’s disease portion of the sentence, not for the other listed diseases. Section 2, “Oxidative damage,” describes oxidative damage in AD, and the Conclusion states that oxidative stress plays an important role in AD pathogenesis. (LLM, conf=0.94)
- Supportedcites [109] Cioffi F. Adam R.H.I. Broersen K. Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease J. Alzheimer’s Dis. JAD 2019 72 981 1017 10.3233/JAD-190863 31744008 PMC6971833 source
The sentence assigns separate citations to each disease; this source supports the Alzheimer’s disease portion. The Introduction reports early hallmarks of oxidative stress in AD, and “Oxidative Damage to Biomacromolecules in Alzheimer’s Disease” describes oxidative damage in AD brain tissue. The source need not support the other diseases, which have their own citations. (LLM, conf=0.92)
- Not checked yetcites [110] Dias V. Junn E. Mouradian M.M. The Role of Oxidative Stress in Parkinson’s Disease J. Park. Dis. 2013 3 461 491 10.3233/JPD-130230 PMC4135313 24252804
- Supportedcites [111] Blesa J. Trigo-Damas I. Quiroga-Varela A. Jackson-Lewis V.R. Oxidative stress and Parkinson’s disease Front. Neuroanat. 2015 9 91 10.3389/fnana.2015.00091 26217195 PMC4495335 source
The citation is attached to the Parkinson’s disease portion of the sentence, not the list of other diseases. The Introduction states that Parkinson’s disease is related to excess reactive oxygen species and that oxidative stress is thought to underlie cellular dysfunction and death in PD. (LLM, conf=0.94)
- Not checked yetcites [112] Browne S.E. Ferrante R.J. Beal M.F. Oxidative stress in Huntington’s disease Brain Pathol. 1999 9 147 163 10.1111/j.1750-3639.1999.tb00216.x 9989457 PMC8098260 source
- Supportedcites [113] Kumar A. Ratan R.R. Oxidative Stress and Huntington’s Disease: The Good, the Bad, and the Ugly J. Huntingt. Dis. 2016 5 217 237 10.3233/JHD-160205 27662334 PMC5310831 source
The citation to this source is attached to Huntington’s disease, not to the other diseases in the sentence. The section “Is Oxidative Stress a Cause or a Consequence in HD Pathology?” reports increased oxidative damage in postmortem HD brains and describes oxidative stress as implicated in HD pathogenesis. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Nrf2 association requires the homodimerization of Keap1 [74].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.4. Keap1-Dependent Nrf2 Regulation
What the sources say
- Supportedcites [74] Zipper L.M. Mulcahy R.T. The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm J. Biol. Chem. 2002 277 36544 36552 10.1074/jbc.M206530200 12145307 source
The Discussion states that the integrity of the Keap1–Nrf2 complex depends on Keap1 dimerization and calls the BTB/POZ dimerization function a prerequisite for Nrf2 binding. The Results (Fig. 3B) also report reduced Nrf2 association with a Keap1 mutant deficient in homodimerization. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
67 more claims · 13 with their cited sources checked
Create a free account to see all 117 claims and to verify the 137 references still open.
- It may state two separate claims as one. 42
- Probably not a substantial claim. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The transcription factor Nrf2 acts as a central regulator of the host’s primary antioxidant defense system [73,74] and determines cellular fate during envenomation.”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 1. Oxidative Stress > 1.1. Reactive Oxygen Species
“superoxide radicals which are readily detoxified to hydrogen peroxide (H2O2) by antioxidant enzymes such as catalase and glutathione peroxidase.”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 1. Oxidative Stress > 1.3. Antioxidant Response Enzymes
“SODs are responsible for the dismutation (simultaneous oxidation and reduction) and breakdown of superoxide radicals into molecular oxygen and hydrogen peroxide”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.7. Keap1-Interacting Proteins
“In 2010, five independent groups discovered the interaction between p62 and Keap1 [77,78,79,80,81].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > References
“78. Baird L. Yamamoto M. The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway Mol. Cell. Biol. 2020 40 e00099-20”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.7. Keap1-Interacting Proteins
“WTX is also involved in oxidative stress regulation through its competitive binding to the Keap1, which inhibits Nrf2 ubiquitination [84].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > References
“84. Copple I.M. Lister A. Obeng A.D. Kitteringham N.R. Jenkins R.E. Layfield R. Foster B.J. Goldring C.E. Park B.K. Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway”
Citations
Cites
1 retracted
Zhou, S., Ye, W., Duan, X., Zhang, M., & Wang, J. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2537-1 · Cited by 18
RetractedRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Reactive oxygen species: Metabolism, oxidative stress, and signal transduction
Apel, K., & Hirt, H. (2004) · Annual Review of Plant Biology · doi:10.1146/annurev.arplant.55.031903.141701 · Cited by 11,723 · cited 3×
“Extensive or prolonged exposure to ROS results in oxidative stress, a deleterious process that damages lipi s, proteins, and nucleic acids in the cell, thereby inhibiting their normal function [2].”
BackgroundInfluentialPolazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Free Radicals in Biology and Medicine
Halliwell, B., & Gutteridge, J. M. C. (2015) · doi:10.1093/acprof:oso/9780198717478.001.0001 · Cited by 8,990
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Free radicals, metals and antioxidants in oxidative stress-induced cancer
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680 · cited 1×
“RNS and ROS often act together to cause cellular damage [8].”
BackgroundOxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
Role of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903
Cited by
Items 901–1,000 of 1,000
Oxygen Free Radicals and Cancer: Protective Role of Endogenous Antioxidants and Natural Compounds
Irfan, Z., Firdous, S. M., Giri, S., & Hashmi, A. (2026) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206459486260128064009
Therapeutic Potential of Spermidine in Rheumatoid Arthritis: Mechanisms and Future Directions
Chen, Y., Zhou, Y., Long, Z.-Y., Peng, Y., Wu, S., Peng, F., Yuan, M., Zhou, Y., Wang, L., & Yuan, H. (2026) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.70610 · Cited by 2
Liu, T., Chen, F., Wu, L., Zhang, H., & Yin, P. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05124-z · Cited by 1
“As a pivotal transcription factor, Nrf2 defends against OS and inflammation by upregulating antioxidant/detoxifying enzymes and suppressing inflammatory responses (Ngo and Duennwald 2022; Hazari et al. 2025).”
Yin, S., Wang, Y., Guo, H., & Zhang, S. (2026) · Chemistry of Materials · doi:10.1021/acs.chemmater.5c03307
Voronkova, O. V., Birulina, J. G., Алексеевич, Ч. Н., Hasanova, R. R., Евгеньевна, Е. И., Ivanov, V. V., & Buyko, E. E. (2026) · I P Pavlov Russian Medical Biological Herald · doi:10.17816/pavlovj632685
Gayibova, S., Nasyrova, G. I., Рахмонова, Г. Г., Sabirova, M., Abduazimova, D., Nikitina, E., Verushkina, O., & Ivanišová, E. (2026) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3354
Peroxiredoxins in Stroke: Friends and Foes
Wan, Y., Zhang, J., Bian, L., Tan, X., Chen, T., Xi, G., Hua, Y., Pandey, A. S., Keep, R. F., & Koduri, S. (2026) · Cells · doi:10.3390/cells15070640 · Cited by 1
“Prxs are regulated at the transcriptional level (e.g., by nuclear factor erythroid 2-related factor 2 (Nrf2), a master regulator of antioxidant mechanisms) [13]), but also by posttranslational modifications such as phosphorylation and acetylation [14].”
Akanda, M. R., Aktaruzzaman, M., Tanoy, N. M., Supty, S. I., Rahman, M. A., Riea, A. T. M., Roy, S., Sabuj, M. S. S., Ahmed, T., & Rahman, M. J. (2026) · Regenerative medicine reports . · doi:10.4103/regenmed.regenmed-d-25-00055
Antioxidant and Cytotoxic Activities of Postpartum Herbal Remedies Use in Aceh, Indonesia
Saudah, S., Rubiah, R., Zumaidar, Z., Salma, I., & Rahmawati, R. (2026) · Malacca Pharmaceutics · doi:10.60084/mp.v4i1.358
Choi, H. J., Kim, M. J., Paik, J. H., Kim, D. J., & Jung, S. K. (2026) · Food Science and Biotechnology · doi:10.1007/s10068-026-02140-w
“Nuclear factor erythroid 2-related factor 2 (NRF2), as a transcriptional factor, binds to antioxidant response elements (AREs) and protects against oxidative stress in cells and tissues (Ngo and Duennwald, 2022).”
Liao, H., Shen, X., Chai, J., wang, K., Wu, J., Yang, J., Chen, M., Mo, G., & Xu, X. (2026) · Integrative Zoology · doi:10.1111/1749-4877.70101
Wang, X., Xing, M., Cui, Y., Gu, X., Zhang, H., & Hao, Y. (2026) · Archives of Animal Nutrition · doi:10.1080/1745039x.2026.2653547
“The Nrf2/Keap1 pathway is a central regulator of cellular antioxidant response (Kansanen et al. 2013; Ngo and Duennwald 2022).”
Panah, S. R., Ale‐Ebrahim, M., Hajikhani, R., Mortazavi, P., & Alibeik, H. (2026) · Journal of Biologically Active Products from Nature · doi:10.1080/22311866.2026.2651439
“These mechanisms are consistent with evidence that such phytochemicals activate Nrf2 pathways 47,48 , increase the expression of antioxidant enzymes (including SOD, catalase, and HO-1), and limit lipid peroxidation; however, confirmation of these pathways in the current model would require targeted…”
Feng, C., Liu, Y., Zhang, C., Niu, L., Dong, J., & Wang, B. (2026) · Drug Delivery and Translational Research · doi:10.1007/s13346-026-02120-x
Gao, X., Guo, W., Liu, P., Yuwen, M., Ren, H., Hu, S., Liu, Z., Tan, R., Liu, K., Yang, Z., et al. (2026) · eLife · doi:10.7554/elife.97632.3
Danaf, D., Karam, L., Sleem, R., Naamani, A. E. R., Eldawra, E., & Ibrahim, J.-N. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04284-5 · Cited by 1
“NRF2 protein levels, a key regulator of oxidative stress responses, were also unchanged following treatment, further supporting that oxidative stress or compensatory redox signaling is not involved in apoptosis in this cancer type [46].”
Saad, H. M., Ashoura, N. R., Salama, A. R., Wasef, L., Elrehim, A. M. A., Essa, B. H., Saleh, N. A., Elsawasany, A., & Awad, A. (2026) · Scientific Reports · doi:10.1038/s41598-026-46954-4
“Therefore, mitochondrial function and ATP synthesis are improved, and the oxidative damage can be prevented 97–99 .”
Mechanistic pathways of dysbiosis in oral cancer development
Niu, L., Al‐Ahmad, A., Scholz, K. J., Cieplik, F., & Wolf, M. (2026) · Advances in immunology · doi:10.1016/bs.ai.2026.04.001
Malik, S., Bora, J., Dhasmana, A., Mondal, S., Preetam, S., Thapliyal, S., Talukdar, N., & Rustagi, S. (2026) · Minerva Biotechnology and Biomolecular Research · doi:10.23736/s2724-542x.26.03332-8
Yu, H., Guo, Y., Wang, X., Guo, W., & Zhang, Y. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1700811
“Nrf2 orchestrates the expression of various antioxidant and phase II detoxification enzyme genes, and is subject to negative regulation by Kelch-like ECH-associated protein 1 (Keap1) (Ngo and Duennwald, 2022).”
Han, J., Cao, Y., Zhang, C., Zhang, Q., Li, J., Xu, H., Zhao, X., & Yu, C. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1775859
Bonifacio, D., Rapisarda, S., Genova, R., & Condorelli, G. A. (2026) · Planta Medica · doi:10.1055/a-2859-4064
Sasanfar, B., Salehi‐Abargouei, A., Parastouei, K., Darabi, Z., Sadeghi-Nodoushan, F., Sarebanhassanabadi, M., Seyedhosseini, S. M., Hosseini, S. S., & Rostami, H. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05749-1
“Nrf2 controls the expression of genes encoding enzymes essential for detoxifying reactive oxygen species (ROS) and free radicals [76].”
Chemokines and redox homeostasis in aging: A dynamic relationship
González, G. O., & Borrás, C. (2026) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2026.112185
Sowunmi, K., Ibrahim, M. O., & Ogundele, O. E. (2026) · Trends in Pharmacology and Toxicology · doi:10.21124/tpt.2026.47.59
Mukherjee, S., Sharma, A., Upadhyay, P., Madan, E., Pati, S., & Singh, S. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.28.721236
Activation of the Nrf2/ARE Pathway Attenuates BDE-47-Induced Immunotoxicity in RAW264.7 Macrophages
Gao, Q., Deng, Q., Yang, Z., Wei, L., & Chen, H. (2026) · Biomolecules · doi:10.3390/biom16050674
“Activation of this pathway induces the expression of a broad range of antioxidant and detoxifying enzymes, thereby enhancing cellular resistance to oxidative damage [28,29].”
Arramrak, K., Witayavanitkul, N., Chayanupatkul, M., Wanpiyarat, N., Siriviriyakul, P., & Werawatganon, D. (2026) · PLoS ONE · doi:10.1371/journal.pone.0347908 · Cited by 1
“These findings are consistent with evidence that vitamin D enhanced GPX activity and glutathione metabolism, through activation of the Nrf2 pathway [71], which regulates the transcription of multiple antioxidant enzymes [72].”
HERNÁNDEZ-PÉREZ, S., Oidor-Chan, V. H., Rivera, J. P., Castrejón-Téllez, V., Oliart‐Ros, R. M., Carreón‐Torres, E., Ibarra-Lara, L., CHÁVEZ-REYES, Y., Castro-Rodríguez, D. C., Mendoza-García, P. G., et al. (2026) · Antioxidants · doi:10.3390/antiox15050592
“Oxidative stress induces conformational modifications in Keap1 cysteine residues, thereby stabilizing NRF2 and promoting nuclear translocation [35].”
Agbonifo, W. O., Chimezie, J., Awoleye, M. O., Francis, H. O., Oguntade, I. A., Aleruwa, S. O., Amoo, Z. A., & Adedeji, T. G. (2026) · The Journal of Nutritional Physiology · doi:10.1016/j.jnphys.2026.100031
Chalcones as antiinflammatory, antiulcer, and antioxidant agents
Iacovozzi, D., Mencarelli, N., & Gallorini, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-43812-7.00014-9
Parimartha, N. L. T., & Laksemi, D. A. A. S. (2026) · Journal of Pharmaceutical And Sciences · doi:10.36490/journal-jps.com.v9i2.1486
“[56] Activation of the Nrf2 pathway enhances the cellular capacity to neutralize oxidative stress and maintain redox balance.”
Natural chalcones in traditional medicine
Uysal, Ş., & Zengin, G. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-43812-7.00007-1
Zhao, W., Luo, Y., Hu, C., Jiang, X., Yao, J., Lu, X., Wang, S., & Fan, X. (2026) · Biomedical Chromatography · doi:10.1002/bmc.70469
Bektur, E., Sarıkaya, B., Saracoglu, S., & Gurpinar, A. O. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11904-w
Cho, I. H., Putra, H. M., Jung, C. W., Hyun, G. H., Jang, H., Hwang, I. G., & Kwon, S. W. (2026) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.70699
“79 These enzymes have pivotal roles in maintaining cellular redox balance, detoxifying ROS, and mitigating oxidative damage.”
Dadzie, H. E., Green, Y. S., Camolotto, S. A., Arnold, H. U., Gumbleton, M., Guo, M., Mino-Kenudson, M. A., Maeda, Y., Spike, B. T., & Snyder, E. L. (2026) · Journal of Clinical Investigation · doi:10.1172/jci198282 · Cited by 1
Al-Rashedi, H. F., Alenazi, R., Alshammari, N. S., Ibrahim, M. A., Mohamed, S. R., & Okail, H. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1817773
“The recurrent engagement of ILE559, a key residue for Nrf2 recognition, suggests competitive occupation of the Nrf2-binding pocket, providing a molecular basis for the protective effects of WP in TA-induced intestinal oxidative stress (66, 67).”
The role of biotics and bioactive compounds in sports injuries: a narrative review
Şahin, K., Dal, N., Gönen, B., Akman, O., Raposa, B. L., & Ağagündüz, D. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1813030
“Nrf2 is a major transcriptional regulator that controls a variety of antioxidant enzymes involved in oxidative stress detoxification (104).”
Li, F.-J., Song, Q.-Y., Wang, Z.-H., Fu, X.-J., & Xu, K. (2026) · Industrial Crops and Products · doi:10.1016/j.indcrop.2026.123465
Dual Role of Ginkgo biloba in Nanoparticle Biosynthesis and Parkinson’s Disease Management
Jagaran, K., & Singh, M. (2026) · Letters in Applied NanoBioScience · doi:10.33263/lianbs151.030
Therapeutic Role of Oxidative Stress in Diabetes
Saha, S., Karande, A. V., Nair, G. G., & Srivastava, N. (2026) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-032-19837-2_7
Flores-Cortez, Y. A., Mendoza-Bello, J. M., Salinas‐Bautista, E., Cortés-Sarabia, K., Ramírez, M., Lamas, M., Calvario‐Pino, R. Y., Sánchez-Alavez, M., & Espinoza-Rojo, M. (2026) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70499 · Cited by 1
“CUR exerts direct free radical scavenging activity by donating electrons or hydrogen atoms [ 40 ], and indirectly activates the Nrf2 pathway, enhancing transcription of antioxidant enzymes such as SOD, GSH-Px, thioredoxin (Trx), HO-1, and PON-1, key contributors to TAC [ 41–43 ].”
Yao, J., Ma, J., Lin, H., Shao, C., Liu, X., & Jin, X. (2026) · Antioxidants · doi:10.3390/antiox15050614
“Nrf2 acts as a key cellular stress sensor, triggering the expression of various antioxidant and cytoprotective genes by binding to ARE [32].”
Ba, K., Mourabiti, F., Khalfi, B. E., Elmakssoudi, A., Lamine, M., & Soukri, A. (2026) · South African Journal of Botany · doi:10.1016/j.sajb.2026.05.009
Eşbah, M. S., Onal, F. R., & Doğan, G. (2026) · Exploration of Foods and Foodomics · doi:10.37349/eff.2026.1010151
The diving reflex elicits potent, non-electrophilic Nrf2 activation via trigeminal CGRP signaling
Li, C., Powell, K., Wadolowski, S., Jacob, A., LeDoux, C., Brenner, M., & Wang, P. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.05.306 · Cited by 2
Bai, S., Tang, Z., Mahemuti, D., Ma, L., Huang, Q., Kong, Y., Chen, Y., Su, Z., Shataera, D., & Maimaitijiang, A. (2026) · Cogent Food & Agriculture · doi:10.1080/23311932.2026.2630417
New Adjuvant Therapies for Obesity-Related Disorders Associated with Meta-Neuroinflammation
Coluzzi, F., Cornali, K., Scerpa, M. S., & Noce, A. (2026) · Pharmaceuticals · doi:10.3390/ph19050786
“Nrf-2 positively modulates the expression of many endogenous antioxidants, namely NAD(P)H oxidoreductase 1 (NQO1), heme oxygenase-1 (HO-1), SOD, glutathione (GSH), and GPx [147,148], and inhibits pro-inflammatory pathways, such as NF-κ B [149], hence reducing levels of inflammatory cytokines [150].”
Admin, A., Mukhoirotin, Purwanto, B., Ernawati, Purba, A. K. R., & Zainiyah, H. (2026) · Malaysian Journal of Medicine and Health Sciences · doi:10.47836/mjmhs.v22i1.1472
“The stimulation of Nrf2-ARE signaling activity enhances genomic responses to the synthesis of endogenous antioxidant molecules, such as SOD, catalase, and glutathione peroxidase (39).”
Wu, D., Zhao, J., Chang, X., Lei, Y., Mu, C., Yang, D., Ye, T., & Xu, S. (2026) · The FASEB Journal · doi:10.1096/fj.202600552rrr
“Although NRF2 is widely recognized as a central regulator of antioxidant responses [47], its protective effect relies on the availability of metabolic substrates.”
Moghtaderi, F., Zimorovat, A., Raeisi‐Dehkordi, H., Amiri, M., Sadeghi-Nodoushan, F., Mahinizadeh, F., Farashahi-Yazd, E., Moradi, A., Fallahzadeh, H., Nadjarzadeh, A., et al. (2026) · Nutrition and Health · doi:10.1177/02601060261453506
Shaan, I., Gulledge, B., Poplavskyi, M., Eubank, M., Domukhovska, A., Weinrieb, A., Alseid, D., Prentice, I., Rosen, S., Rayan, G., et al. (2026) · Cells · doi:10.3390/cells15110975
“A likely explanation involves SF’s dual role in redox regulation: while it activates Nrf2 to induce antioxidant defenses [26,27], SF has also been shown to increase intracellular ROS in cancer cells [42], and in the context of our experiments where NTP and TPZ already impose substantial oxidative…”
Su, X., Zhang, Y., Xin, H., Na, S., & Cui, Y. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109160
Jing, X., Cai, L., Guan, Y., Liu, S., Li, Y., Li, G., Li, Y., Pei, Z., Yifei, 王. W., & Zhang, Y. (2026) · Neuroreport · doi:10.1097/wnr.0000000000002273
Giri, S., & Chandra, P. (2026) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2026.00292
Wang, K., Qiao, X., Shengling, Y., Tumayhi, N. A., Mashhour, Y. K., Shami, A. T., & Farasani, A. (2026) · Pharmacognosy Magazine · doi:10.1177/09731296261450312
“Thus, the NRF2–Keap1 pathway constitutes the initial line of defence against ROS-mediated cardiac injury (Ngo & Duennwald, 2022; Singh et al., 2022).”
Song, K. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1811143
“Upon oxidative challenge, Nrf2 dissociates from Keap1, translocates to the nucleus, and promotes transcription of downstream antioxidant genes such as heme oxygenase-1 (HO-1) and NAD(P)H quinone oxidoreductase 1 (NQO1) (Ngo and Duennwald, 2022).”
InfluentialEffect of zymosan-induced peritonitis on carp reproductive parameters and seminal plasma proteome
Kolek, L., Szczygiel, J., Kamińska-Gibas, T., Dietrich, M., Świderska, B., Malinowska, A., Ples, M., & Irnazarow, I. (2026) · Aquaculture · doi:10.1016/j.aquaculture.2026.744267
Moretti, E., Signorini, C., Liguori, L., Leoni, E., & Collodel, G. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27115079
“During cellular stress, the high ROS concentrations disrupt the interaction between Keap1 and Nrf2 and allow stabilized or newly synthesized Nrf2 [13] to accumulate and translocate into the nucleus.”
Zhang, D., Zhang, L., Zhang, L., Jia, H., Zhao, X., Ren, S., Wu, Y., Zhu, Y., & Zhang, X. (2026) · Molecular Diversity · doi:10.1007/s11030-026-11602-6
Abdalla, H. A., Elmorsy, E. M., Jawad, N. M. M., Hosny, N., Shams, A. S., Ayaz, R. A., Fawzy, M. S., & Elshopakey, G. E. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05521-4
“…mecha‑ nism that enhances antioxidant defenses, whereas TLR4/ NF‑κB and JAK2/STAT1 pathways mediate pro‑inflamma‑ tory responses and cytokine production, collectively con‑ tributing to the progression of diabetic liver injury (Ngo and Duennwald 2022; Sarapultsev et al. 2023; Liu et al. 2025b).”
Ghzaiel, I., Moreau, M., Ali, S., Quoniou, R., Baron, S., Perisse, F., Lobaccaro, J. A., & Menecier, S. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154110
Wang, Z., Wu, D., Jiao, J., Wu, Q., & Dong, X. (2026) · Food Research International · doi:10.1016/j.foodres.2026.119604
Ganguly, A. K., Banerjee, S. K., Sagar, G. V. V., Singal, D. K., & Ganguly, A. (2026) · Clinical Phytoscience · doi:10.1186/s40816-026-00428-2
Cai, S., Zhou, C., Zhou, Z., Bao, R., Hu, L., Pan, J., Hu, B., & Yin, J. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.215001
Li, M., Zhou, R., Guo, L., Liu, Y., Lu, D., Chen, H., Xü, W., Peng, J., Wu, W., Yu, J., et al. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6c01060
Sun, G., Dong, Y., Deng, J., Wang, Y., Cao, X., Lu, W., Chen, K., Xie, Y., Huang, B., & Chen, Y. (2026) · Advanced Functional Materials · doi:10.1002/adfm.202523503
Guzman, L., Parcerisas, A., Olloquequi, J., Marqués, A. M., Cano, A., Sánchez‐López, E., Verdaguer, E., Auladell, C., Cajal, Y., Barenys, M., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118154 · Cited by 1
Kim, M., & Hahn, J.-H. (2026) · Cosmetics · doi:10.3390/cosmetics13030150
“Emerging evidence indicates that VDR signaling may functionally intersect with antioxidant defense pathways, particularly those governed by nuclear factor erythroid 2-related factor 2 (NRF2) [14–16].”
Gao, C., Sun, S., Zhang, W., Lin, Z., Yan, X., Bai, L., Zhang, Y., Lin, S., Chen, M., Chen, D., et al. (2026) · Animals · doi:10.3390/ani16121807
Peter, I. E., Emenalo, M. C., Agbo, C. E., Onwuka, A. M., Abonyi, H. N., Ezugwu, M. C., Alozie, E. M., Isiogugu, O. N., Ofokansi, M. N., Mbaoji, F. N., et al. (2026) · American Journal of Pharmacotherapy and Pharmaceutical Sciences · doi:10.25259/ajpps_2026_013
Fiorino, S., Hong, W., de Biase, D., Mastrangelo, L., Maccioni, F., Grottesi, A., Ambrosi, F., Pincigher, L., Lari, F., Bergamini, C., et al. (2026) · Cancers · doi:10.3390/cancers18121932
“Furthermore, RA interacts with NRF2 signaling [305]: it can enhance NRF2 transcription under physiological conditions, but paradoxically, it normalizes aberrant NRF2 activation in malignant cells, restoring redox balance without fostering their survival [306,307].”
Xia, Z., Zhao, M., Lu, J., Wang, J., & Duan, R. (2026) · iScience · doi:10.1016/j.isci.2026.116297
“84 To further reinforce the defense, Auto-phagy degrades KEAP1 in the KEAP1-Nrf2 complex, thereby liberating Nrf2 to induce antioxidant enzyme genes, such as Sqstm1 , Sesn2 , and Pin k. Crucially, the functional integrity of these antioxidant defenses dictates the bifurcation of cell fate between…”
Born early, age fast: Consequences of premature birth on chronic disease and accelerated ageing
Gauda, E. B., Ivanovska, J., Mascarenhas, D., Antwi, J., Mohammadi, A., & Jasani, B. (2026) · The Journal of Physiology · doi:10.1113/jp289277 · Cited by 1
Chemical challenge is an ancient evolutionary pressure
Costa, P. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-85779-6.00008-8
Şekeroğlu, Z. A., Şekeroğlu, V., Kamanlı, Ş., Yedier, S. K., Aydın, B., & Kasurka, C. B. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70972
“PYC activates Nrf2‐ dependent transcription by strengthening antioxidant defenses, including GSH and superoxide dismutase (SOD), while concurrently inhibiting ROS‐sensitive NF‐κB signaling pathways, thereby alleviating oxidative stress and related pro‐ inflammatory responses [56].”
Monmai, C., Tangonan, A. C., Kim, J.-S., Rha, E.-S., & Baek, S.-H. (2026) · Natural Product Research · doi:10.1080/14786419.2026.2691377
Ramadhani, D., Farah, H. I., & Ramadhani, H. A. (2026) · Jurnal Sains dan Kesehatan · doi:10.30872/jsk.v7i2.1125
da SILVA, F., Cappellaro, G. L., Zazula, M. F., Dahleh, M. M. M., Prigol, M., Guerra, G. P., Lc, F., Bertolini, G. R. F., Torrejais, M. M., Naliwaiko, K., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9999084/v1
Paliwal, S., Bhardwaj, J. S., & Taliyan, R. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00234
Fluorouridine labeling enables spatiotemporal mapping of transcriptomes and enhancers in vivo
Feng, Y., Zhang, Y., Lian, H., Wang, Z., Wang, J., Wu, L., David, C. J., Chen, F., & Basnet, H. (2026) · Nature Communications · doi:10.1038/s41467-026-74725-2
“Interestingly, multiple genes involved in antioxidant defense, including Nfe2l2 (Nrf2), the master regulator of antioxidant defense 18 , and some genes involved in regulation of circadian rhythm were downregulated by both anesthetics (Fig.”
Li, C., Wang, J., & Sun, J. Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1868492 · Cited by 1
“As part of its response to in fl ammation, the body can activate oxidative stress resistance mechanisms (such as those centered around the transcription factor NRF2) in addition to inducing in fl ammatory mechanisms (97).”
Oxidative stress and antioxidants in breast cancer: a double-edged sword
Adegoke, A. M., Igomu, G. O., Usin, S. G., & Sekhoacha, M. P. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1828367 · Cited by 1
“Breast cancer is a result of a genetic mutation, as discovered in the mutation of germline Breast Cancer gene 1 ( BRCA1 ), which leads to basal breast cancer (6).”
InfluentialZhang, Y. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70935
Meng, F., Wu, Y., Yang, Y., Cao, C., Ling, X., Zhang, L., Cui, X., Li, T., Wang, S., Luo, X., et al. (2026) · Journal of Integrative Agriculture · doi:10.1016/j.jia.2026.06.032
Sanjaya, B. R. L., Wahyudia, L. D., & Cho, M. K. (2026) · Journal of Ginseng Research · doi:10.1016/j.jgr.2026.101079
“Nrf2 dysregulation has been linked to diverse diseases associated with oxidative stress [24].”
Du, Y., Bilal, M., & Wang, P. (2026) · Grain & Oil Science and Technology · doi:10.1016/j.gaost.2026.06.004
NRF2 Gene Polymorphisms, Preconception BMI and Their Interplay in Preeclampsia
Li, Z., Guo, S., Zhou, X., Miao, J., Xia, F., Chen, L., & Wang, T. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135705
Hagawa, H., Ichikawa, E., Otake, K., Ishii, M., & Kawaguchi, N. (2026) · PLoS ONE · doi:10.1371/journal.pone.0351422
Dietary source of flavonoids, mode of intake, bioavailability, and toxicity
Kashyap, D., Sharma, R., Munda, V. S., Garg, V. K., Thakur, S., Sharma, D., & Okpala, C. O. R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-42855-5.00003-0
Anyanwu, G. E., CHUKWU, V. O., Nto, N. J., Ojiakor, V. O., & Anyanwu, C. N. (2026) · Behavioral and Brain Functions · doi:10.1186/s12993-026-00348-8 · Cited by 1
“During oxidative stress, Nrf2 is dissociated with its inhibitor Keap1 and translocates to the nucleus to cause the expression of cytoprotective enzymes (e.g., heme oxygenase-1, glutathione S-transferases) [26].”
Yuan, J., Wu, D., Xu, H., Jiao, J., Yang, C. R., Wu, X., Liu, W., & Hao, E. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1830736
“…(Nrf2), a key intracellular redox-sensing transcription factor, regulates multiple antioxidant genes to maintain cellular oxidative homeostasis (Ngo and Duennwald, 2022 and oxidative stress exhibit a bidirectional relationship: sleep deprivation elevates systemic oxidative stress, and Nrf2, as…”
Epigenetic Regulations by Olive Bioactives: Targeting HDAC for Disease Prevention and Therapy
Debnath, M., Sharma, S., Joshi, S., & Aneja, D. (2026) · Current Nutrition Reports · doi:10.1007/s13668-026-00779-9
Neuroinflammation and Tauopathies
Zeenny, M.-N., Salame, I., Maatouk, L., & Akoury, E. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12253-4
Synergistic Geroprotectors Mapping through Systems Machine Learning and Graph Neural Networks
Sharma, Y., & Das, A. (2026) · OMICS A Journal of Integrative Biology · doi:10.1177/15578100261464019
“…stress-response pathways (Armeli et al., 2024; Bia ł opiotrowicz-Data et al., 2023; Esteras and Abra-mov, 2022; Garcia and Shaw, 2017; Herzig and Shaw, 2018; Huang et al., 2024; Laplante and Sabatini, 2012; Lee, 2019; Monsalvo-Maraver et al., 2024; Ngo and Duennwald, 2022; Pan-war et al., 2023).”
A review on Nrf2 and antioxidant metalloproteins
Hossain, A. M. S., Qudratovna, Q. M., Kholnazarov, B. A., Odaka, A., Nakane, D., & Akitsu, T. (2026) · European Journal of Chemistry · doi:10.5155/eurjchem.17.2.176-187.2773
Olokede, E. U., Tata, L., & Adeniji, A. A. (2026) · International Journal of Evidence-Based Medicine · doi:10.63946/jebm/18873
Medicinally Important Natural Chalcones
Mukherjee, A., Chauhan, S. C., & Bandyopadhyay, D. (2026) · Springer eBooks · doi:10.1007/978-3-642-36202-6_299-1
Metadata
- Authors
- Ngo, V., & Duennwald, M. L.
- Affiliations
- Western University (CA)
- Corresponding author
- Duennwald, Martin L.
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2022-11-27
- Volume
- 11
- Issue
- 12
- Pages
- 2345
- ISSN
- 2076-3921 (ISSN-L)
- PMC
- PMC9774434
- OpenAlex
- W4310211651
- Semantic Scholar
- ae6aa01efc202b0f3f701cefd15f11f215aa3aa5
- Cited by
- 1,130
- References
- 236
- Citations by year
- 2026: 415 · 2025: 448 · 2024: 200 · 2023: 67
- FWCI
- 18.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Antioxidants (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- TBCRU (n/a)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Keywords
- Nrf2, oxidative stress, reactive oxygen species, antioxidant defense, antioxidant enzymes, Nrf2 activation, neurodegenerative diseases, cardiovascular disease, diabetes mellitus, cancer, detoxification
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.